Authors: Lalej-Bennis, D Boillot, J Bardin, C Zirinis, P Coste, A Escudier, E Chast, F Peynegre, R Slama, G Selam, JL

Citation: D. Lalej-bennis et al., Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: Efficacy vs subcutaneous injectionsand local tolerance, DIABETE MET, 27(3), 2001, pp. 372-377

Authors: Lalej-Bennis, D Boillot, J Bardin, C Zirinis, P Coste, A Escudier, E Chast, F Peynegre, R Selam, JL Slama, G

Citation: D. Lalej-bennis et al., Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure:a cross-over study, DIABET MED, 18(8), 2001, pp. 614-618

Authors: Piketty, C Bardin, C Gilquin, J Gairard, A Kazatchkine, MD Chast, F

Citation: C. Piketty et al., Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis, CL MICRO IN, 6(3), 2000, pp. 117-120

Authors: Marie, JP Marjanovic, Z Vekhoff, A Bouvet, A Chast, F Levy, V Baudard, M Legrand, O Rio, B Delmer, A Zittoun, R

Citation: Jp. Marie et al., Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycinas empiric therapy for fever in severely neutropenic patients, SUPP CARE C, 7(2), 1999, pp. 89-94